Meta-analysis: half of glaucoma-drainage-device eyes lose EK grafts by 3 years
A systematic review and meta-analysis of 22 retrospective studies (943 grafts) pooled outcomes of endothelial keratoplasty in eyes with prior glaucoma surgery, comparing DSAEK and DMEK. The analysis reported 36-month graft survival of 57% overall and 50% in eyes with prior glaucoma drainage device implantation, with higher endothelial cell loss and graft dislocation rates in GDD eyes; head-to-head comparisons found no significant difference between DSAEK and DMEK through 24 months. The authors state prospective registries with standardized endpoints are needed.
Most relevant for: Patients with prior glaucoma surgery, including glaucoma drainage device implantation, being considered for endothelial keratoplasty.
Read the original at American Journal of OphthalmologySummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More ophthalmology updates
- Multisociety task force disputes need for routine high-level disinfectionOct 9, 2026
- Donor Diabetes Severity Not Linked to DMEK Graft OutcomesOct 8, 2026
- AAO review finds injection and sponge MMC comparably effective in trabeculectomyOct 7, 2026
- Home tonometry metrics linked to visual field loss in glaucomaSep 30, 2026
- Meta-analysis confirms teprotumumab benefits and side effects in thyroid eye diseaseSep 29, 2026